[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN110200839A - The application of big rat-tail Type I collagen albumen - Google Patents

The application of big rat-tail Type I collagen albumen Download PDF

Info

Publication number
CN110200839A
CN110200839A CN201910520678.5A CN201910520678A CN110200839A CN 110200839 A CN110200839 A CN 110200839A CN 201910520678 A CN201910520678 A CN 201910520678A CN 110200839 A CN110200839 A CN 110200839A
Authority
CN
China
Prior art keywords
parts
collagen
test
rat tail
tail type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910520678.5A
Other languages
Chinese (zh)
Inventor
张文众
张崇霄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North China Institute of Science and Technology
Original Assignee
North China Institute of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North China Institute of Science and Technology filed Critical North China Institute of Science and Technology
Priority to CN201910520678.5A priority Critical patent/CN110200839A/en
Publication of CN110200839A publication Critical patent/CN110200839A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988Honey; Royal jelly, Propolis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

本发明公开了大鼠尾Ⅰ型胶原蛋白的应用。本发明大鼠尾Ⅰ型胶原蛋白应用于制备防皱保湿和/或美白的产品中。本发明大鼠尾Ⅰ型胶原蛋白的防皱保湿、美白产品更有利于人皮肤成纤维细胞的迁移,证明本发明品有利于皮肤的防皱保湿。本发明大鼠尾Ⅰ型胶原蛋白具有对络氨酸酶活性抑制作用,证明其具有美白作用。本发明大鼠尾Ⅰ型胶原蛋白具有安全无毒副作用的特点。The invention discloses the application of rat tail type I collagen. The rat tail type I collagen of the present invention is applied to the preparation of anti-wrinkle moisturizing and/or whitening products. The anti-wrinkle moisturizing and whitening product of the rat tail type I collagen of the present invention is more conducive to the migration of human skin fibroblasts, which proves that the product of the present invention is beneficial to the anti-wrinkle and moisturizing of the skin. The rat tail type I collagen of the present invention has an inhibitory effect on tyrosinase activity, which proves that it has a whitening effect. The rat tail type I collagen of the invention has the characteristics of safety and no side effects.

Description

大鼠尾Ⅰ型胶原蛋白的应用Application of Rat Tail Type Ⅰ Collagen

技术领域technical field

本发明涉及大鼠尾Ⅰ型胶原蛋白的应用,具体涉及一种鼠尾Ⅰ型胶原蛋白在制备美白除皱化妆品中的应用和一种化妆品,属于化妆品领域。The invention relates to the application of rat tail type I collagen, in particular to the application of rat tail type I collagen in the preparation of whitening and anti-wrinkle cosmetics and a cosmetic, belonging to the field of cosmetics.

背景技术Background technique

鼠尾Ⅰ型胶原蛋白(Collagen from rat tail,Type I)系采用Birkedal-Hansen方法在无菌下制备,纯度达到95%以上,可溶于0.006mol/L乙酸。本品可用于细胞培养皿的包被,特别适合普通细胞培养器皿不易贴壁细胞的培养;也可用于制备三维胶原凝胶,使细胞在模拟的三维环境中生长。它广泛应用关于细胞培养中。Rat tail type Ⅰ collagen (Collagen from rat tail, Type I) is prepared under aseptic conditions by the Birkedal-Hansen method, with a purity of over 95%, soluble in 0.006mol/L acetic acid. This product can be used for the coating of cell culture dishes, especially suitable for the cultivation of cells that are not easy to adhere to in ordinary cell culture dishes; it can also be used for the preparation of three-dimensional collagen gel, so that cells can grow in a simulated three-dimensional environment. It is widely used in cell culture.

牡丹花提取物富含天然抗氧化活性成分,保护皮肤受到外源性自由基的损伤。Peony flower extract is rich in natural antioxidant active ingredients to protect the skin from exogenous free radical damage.

蜂胶提取物富含免疫活性因子,增强皮肤的免疫力,预防皮肤感染。Propolis extract is rich in immune active factors, which can enhance the immunity of the skin and prevent skin infections.

发明内容Contents of the invention

本发明的目的是提供大鼠尾Ⅰ型胶原蛋白的应用,具体提供一种鼠尾Ⅰ型胶原蛋白在制备美白除皱化妆品中的应用。The purpose of the present invention is to provide the application of rat tail type I collagen, specifically to provide an application of rat tail type I collagen in the preparation of whitening and anti-wrinkle cosmetics.

本发明提供的大鼠尾Ⅰ型胶原蛋白应用于制备防皱保湿和/或美白的产品中。The rat tail type I collagen provided by the invention is used in the preparation of anti-wrinkle moisturizing and/or whitening products.

上述的应用中,所述产品包括食品、化妆品和保健品中的至少一种。In the above application, the product includes at least one of food, cosmetics and health products.

本发明还提供了一种防皱保湿和/或美白的化妆品,其活性成分为所述大鼠尾Ⅰ型胶原蛋白。The present invention also provides an anti-wrinkle moisturizing and/or whitening cosmetic, the active ingredient of which is the rat tail type I collagen.

本发明中,所述大鼠尾Ⅰ型胶原蛋白的制备方法包括如下步骤:In the present invention, the preparation method of the rat tail type I collagen comprises the following steps:

1、取大鼠尾巴洗净,75%酒精浸泡5分钟;1. Wash the rat tail and soak it in 75% alcohol for 5 minutes;

2、.将尾巴剪开、去掉皮毛,并剪成小段,抽出银色的尾键;2. Cut the tail, remove the fur, cut it into small pieces, and pull out the silver tail key;

3、将尾腱剪断置于平皿中,PBS(pH7.2~7.4,KH2PO4 2mM,Na2HPO4 8mM, NaCl136mM,KCl 2.6mM)浸泡;3. Cut off the tail tendon and place it in a plate, soak it in PBS (pH 7.2-7.4, KH 2 PO 4 2mM, Na 2 HPO 4 8mM, NaCl 136mM, KCl 2.6mM);

4、将所有的尾键放于0.05mol/L的Tris-HCl中,4℃过夜;4. Put all tail bonds in 0.05mol/L Tris-HCl, overnight at 4°C;

5、吸去Tris-HCl,将尾腱称重(0.5-1克);5. Suck off the Tris-HCl, and weigh the tail tendon (0.5-1 g);

6、将尾腱置于平皿内剪碎,转移至三角烧瓶中;6. Put the tail tendon in a plate, cut it into pieces, and transfer it to an Erlenmeyer flask;

7、按每克尾腱50mL的比例,加入0.1%醋酸溶液;7. Add 0.1% acetic acid solution at a ratio of 50 mL per gram of tail tendon;

8、摇晃,使尾腱分散于醋酸溶液中,4℃放置一星期;8. Shake to disperse the tail tendon in the acetic acid solution, and place it at 4°C for a week;

9、离心,4度4000转/分,30分钟;9. Centrifuge, 4 degrees, 4000 rpm, 30 minutes;

10、吸取上清,过300目滤器;10. Take the supernatant and pass it through a 300-mesh filter;

11、每600ml上述粗提液中加入100ml 0.14mol/LNaOH(5.6gNaOH溶到1000毫升水中),8000转5min离心,弃上清,留絮状沉淀;11. Add 100ml 0.14mol/L NaOH (5.6gNaOH dissolved in 1000ml water) to every 600ml of the above crude extract, centrifuge at 8000 rpm for 5min, discard the supernatant, and leave flocculent precipitate;

12、将絮状沉淀物置于三蒸水中,用0.1mol/L(1000:6)醋酸溶解沉淀物。12. Place the flocculent precipitate in triple distilled water, and dissolve the precipitate with 0.1mol/L (1000:6) acetic acid.

本发明还提供了一种化妆品,该化妆品包括如下质量份的组分制成:大鼠尾Ⅰ型胶原蛋白2~3份;牡丹花提取物0.5~1份;蜂胶提取物0.6~1.2份;氢化聚癸烯3份;辛酸癸酸三甘油酯4份;二甲基硅油3份;鲸蜡醇1.2份;山嵛醇0.5份;异十三醇异壬酸酯4份;水100份;甘油3份;丁二醇3份;甘油硬脂酸(SE)1份;山嵛醇聚醚-20 1.5份;乙二胺四乙酸二钠0.03份;丙烯酸钠酰二甲基牛磺酸钠共聚物0.5份;防腐剂0.2份;香精0.1~0.3份。The present invention also provides a cosmetic, which is made of the following components by mass: 2-3 parts of rat tail type I collagen; 0.5-1 part of peony flower extract; 0.6-1.2 parts of propolis extract; 3 parts of hydrogenated polydecene; 4 parts of caprylic capric triglyceride; 3 parts of simethicone; 1.2 parts of cetyl alcohol; 0.5 parts of behenyl alcohol; 4 parts of isotridecanyl isononanoate; 100 parts of water; 3 parts of glycerin; 3 parts of butanediol; 1 part of glyceryl stearic acid (SE); 1.5 parts of beheneth-20; 0.03 parts of disodium edetate; sodium acrylate sodium dimethyl taurate 0.5 parts of copolymer; 0.2 parts of preservative; 0.1 to 0.3 parts of essence.

本发明中,所述牡丹花提取物和所述蜂胶提取物为本领域公知的提取物或均按照本领域公知的方法提取。In the present invention, the peony flower extract and the propolis extract are extracts known in the art or are extracted according to methods known in the art.

本发明进一步提供了上述化妆品的制备方法,包括如下步骤:1)将氢化聚癸烯、辛酸癸酸三甘油酯、二甲基硅油、鲸蜡醇、山嵛醇和异十三醇异壬酸酯混合,加热得到A相;The present invention further provides a preparation method for the above-mentioned cosmetics, comprising the steps of: 1) mixing hydrogenated polydecene, caprylic triglyceride, simethicone, cetyl alcohol, behenyl alcohol and isotridecanyl isononanoate Mix and heat to obtain phase A;

2)将大鼠尾Ⅰ型胶原蛋白、牡丹花提取物水、甘油、丁二醇、甘油硬脂酸、山嵛醇聚醚-20和乙二胺四乙酸二钠混合得到B相,然后将步骤1)中得到的所述A相加入所述B相中,预乳化、均质;2) Mix rat tail type Ⅰ collagen, peony flower extract water, glycerin, butylene glycol, glyceryl stearic acid, beheneth-20 and disodium edetate to obtain phase B, and then The phase A obtained in step 1) is added to the phase B, pre-emulsified and homogenized;

3)经步骤2)中所述A相与所述B相经处理后,加入丙烯酸钠酰二甲基牛磺酸钠共聚物混合;3) After the A phase and the B phase described in step 2) are treated, add sodium acrylate sodium acyl dimethyl taurate copolymer and mix;

4)将步骤3)处理后的体系冷却,然后加入防腐剂、香精均质,即得到所述化妆品。4) Cool the system after the treatment in step 3), and then add preservatives and essence to homogenize to obtain the cosmetic.

上述的制备方法,步骤1)中,所述加热至80℃;In the above preparation method, in step 1), the heating is to 80°C;

步骤2)中,所述预乳化的时间为5min,所述均质的时间为3min;In step 2), the time of the pre-emulsification is 5min, and the time of the homogenization is 3min;

步骤3)中,所述体系冷却至45℃;In step 3), the system is cooled to 45°C;

步骤4)中,所述均质的时间为2min。In step 4), the homogenization time is 2 minutes.

本发明具有以下优点:The present invention has the following advantages:

本发明大鼠尾Ⅰ型胶原蛋白及其制备的配方化妆品具有防皱保湿、美白的功效,更有利于人皮肤成纤维细胞的迁移,证明本发明品有利于皮肤的修复防皱保湿。本发明大鼠尾Ⅰ型胶原蛋白具有对络氨酸酶活性抑制作用,证明其具有美白作用。本发明大鼠尾Ⅰ型胶原蛋白的急性皮肤刺激性试验,急性眼刺激性试验,皮肤光毒性试验,皮肤变态反应试验,体外哺乳动物细胞染色体畸变试验均未见毒性反应。本发明大鼠尾Ⅰ型胶原蛋白经口急性毒性试验MTD均大于15.0g/kgBW;遗传毒性试验:Ames 试验、小鼠骨髓嗜多染红细胞微核试验均未见有致突变作用;90天喂养试验结果显示未见对动物体重、食物利用率、血液学、血生化、脏体比和病理组织学检查有不良影响。本发明大鼠尾Ⅰ型胶原蛋白具有安全无毒副作用的特点。The rat tail type I collagen and the formula cosmetic prepared by the invention have anti-wrinkle, moisturizing and whitening effects, and are more conducive to the migration of human skin fibroblasts, which proves that the product of the invention is beneficial to skin repair, anti-wrinkle and moisturizing. The rat tail type I collagen of the present invention has an inhibitory effect on tyrosinase activity, which proves that it has a whitening effect. No toxic reaction is found in the acute skin irritation test, acute eye irritation test, skin phototoxicity test, skin allergy test, and mammalian cell chromosome aberration test of the rat tail type I collagen of the present invention. The oral acute toxicity test MTD of rat tail type Ⅰ collagen of the present invention is all greater than 15.0g/kgBW; genetic toxicity test: Ames test, mouse bone marrow polychromatic erythrocyte micronucleus test has no mutagenic effect; 90-day feeding test The results showed that there was no adverse effect on animal body weight, food utilization rate, hematology, blood biochemistry, viscera body ratio and histopathological examination. The rat tail type I collagen of the invention has the characteristics of safety and no side effects.

具体实施方式Detailed ways

下述实施例中所使用的实验方法如无特殊说明,均为常规方法。The experimental methods used in the following examples are conventional methods unless otherwise specified.

下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。The materials and reagents used in the following examples can be obtained from commercial sources unless otherwise specified.

下述实施例中,大鼠尾Ⅰ型胶原蛋白的制备方法包括如下步骤:In the following examples, the preparation method of rat tail type I collagen comprises the following steps:

1、取大鼠尾巴洗净,75%酒精浸泡5分钟;1. Wash the rat tail and soak it in 75% alcohol for 5 minutes;

2、将尾巴剪开、去掉皮毛,并剪成小段,抽出银色的尾键;2. Cut the tail, remove the fur, cut it into small pieces, and pull out the silver tail key;

3、将尾腱剪断置于平皿中,PBS(pH7.2~7.4,KH2PO4 2mM,Na2HPO4 8mM, NaCl136mM,KCl 2.6mM)浸泡;3. Cut off the tail tendon and place it in a plate, soak it in PBS (pH 7.2-7.4, KH 2 PO 4 2mM, Na 2 HPO 4 8mM, NaCl 136mM, KCl 2.6mM);

4、将所有的尾键放于0.05mol/L的Tris-HCl中,4℃过夜;4. Put all tail bonds in 0.05mol/L Tris-HCl, overnight at 4°C;

5、吸去Tris-HCl,将尾腱称重(0.5-1克);5. Suck off the Tris-HCl, and weigh the tail tendon (0.5-1 g);

6、将尾腱置于平皿内剪碎,转移至三角烧瓶中;6. Put the tail tendon in a plate, cut it into pieces, and transfer it to an Erlenmeyer flask;

7、按每克尾腱50mL的比例,加入0.1%醋酸溶液;7. Add 0.1% acetic acid solution at a ratio of 50 mL per gram of tail tendon;

8、摇晃,使尾腱分散于醋酸溶液中,4℃放置一星期;8. Shake to disperse the tail tendon in the acetic acid solution, and place it at 4°C for a week;

9、离心,4度4000转/分,30分钟;9. Centrifuge, 4 degrees, 4000 rpm, 30 minutes;

10、吸取上清,过300目滤器;10. Take the supernatant and pass it through a 300-mesh filter;

11、每600ml上述粗提液中加入100ml 0.14mol/LNaOH(5.6gNaOH溶到1000毫升水中),8000转5min离心,弃上清,留絮状沉淀;11. Add 100ml 0.14mol/L NaOH (5.6gNaOH dissolved in 1000ml water) to every 600ml of the above crude extract, centrifuge at 8000 rpm for 5min, discard the supernatant, and leave flocculent precipitate;

12、将絮状沉淀物置于三蒸水中,用0.1mol/L(1000:6)醋酸溶解沉淀物。12. Place the flocculent precipitate in triple distilled water, and dissolve the precipitate with 0.1mol/L (1000:6) acetic acid.

实施例1、配方化妆品、大鼠尾Ⅰ型胶原蛋白防皱保湿、美白功能实验Example 1, Formula Cosmetics, Rat Tail Type Ⅰ Collagen Anti-wrinkle Moisturizing, Whitening Function Experiment

配方化妆品:活性成分为鼠尾I型胶原蛋白,牡丹花提取物、蜂胶提取物,具有保湿、防皱、美白作用,其具体配方为表1所示,Formulated cosmetics: the active ingredients are rattail type I collagen, peony flower extract, and propolis extract, which have moisturizing, anti-wrinkle, and whitening effects. The specific formula is shown in Table 1.

表1Table 1

配方化妆品的制备方法,具体包括如下步骤:分别将A相中各组分加入容器A中,加热到80℃;同时将B相中各组分加入容器B中,加热到80℃;在搅拌B相的同时,将A相加入,预乳化5min,然后均质3min;在搅拌的同时,将C相组分加入;搅拌降温冷却,待产品冷却到45℃后,加入D相各组分,均质2min;继续搅拌冷却,降到室温即可。The preparation method of formula cosmetics specifically includes the following steps: adding each component in phase A into container A and heating to 80°C; simultaneously adding each component in phase B into container B and heating to 80°C; At the same time as the phase, add phase A, pre-emulsify for 5 minutes, and then homogenize for 3 minutes; while stirring, add the components of phase C; Mass for 2 minutes; continue to stir and cool down to room temperature.

一、大鼠尾Ⅰ型胶原蛋白的皮肤防皱保湿功能验证性实验:1. Validation experiment of skin anti-wrinkle and moisturizing function of rat tail type Ⅰ collagen:

1、材料与方法1. Materials and methods

1.1主要仪器设备1.1 Main instruments and equipment

实验用主要仪器设备见表2。The main equipment used in the experiment is shown in Table 2.

表2实验用主要仪器设备一览表Table 2 List of main instruments and equipment used in the experiment

1.2主要试剂1.2 Main reagents

主要试剂见表3。The main reagents are listed in Table 3.

表3主要检测试剂一览表Table 3 List of main detection reagents

1.3实验方法1.3 Experimental method

1.3.1胶原铺板:1.3.1 Collagen plating:

把大鼠尾Ⅰ型胶原蛋白、牛骨Ⅰ型胶原蛋白、鱼皮蛋白用无菌0.006mol/L乙酸(0.36g/L)将分别稀释到0.1mg/mL。在超净台上以0.22μm的微孔滤膜过滤除菌,然后分装于EP管里。用之前一天晚上铺板-根据经验是按5μg/cm2的密度,置于消毒的超净台过夜(最好是18小时以上,时间太短胶原难以真正贴附),晾干。以无菌PBS 液冲洗2遍,再以细胞培养液冲洗1遍,最后接种细胞。Rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein were diluted to 0.1 mg/mL with sterile 0.006 mol/L acetic acid (0.36 g/L). Sterilize by filtration with a 0.22 μm microporous membrane on a clean bench, and then dispense into EP tubes. Lay the board the night before use - based on experience, place it on a sterilized ultra-clean bench overnight (preferably more than 18 hours, the time is too short for collagen to really attach), and dry it at a density of 5 μg/cm 2 . Rinse twice with sterile PBS solution, then wash once with cell culture medium, and finally inoculate cells.

1.3.2细胞传代与增殖:1.3.2 Cell passage and proliferation:

用含体积百分浓度10%胎牛血清和体积百分含量1%青链霉素的DMEM-H培养基,放人37℃、体积百分含量5%CO2:的细胞培养箱中进行培养。待细胞汇集率达到培养板底面积90%以上时,采用0.25%胰蛋白酶消化,进行传代培养。取第3~6代细胞用于后续研究。Use DMEM-H medium containing 10% fetal bovine serum by volume and 1% penicillin and streptomycin by volume, and put it in a cell culture box at 37°C and 5% CO 2 by volume for cultivation . When the confluence rate of the cells reached more than 90% of the bottom area of the culture plate, they were digested with 0.25% trypsin and subcultured. The 3rd to 6th passage cells were used for follow-up research.

1.3.3划痕实验:1.3.3 Scratch test:

划痕实验利用倒置显微镜观察细胞生长情况及形态变化。划痕法检测不同胶原对人成纤维细胞迁移的影响取第3~6代人成纤维细胞,接种于大鼠尾Ⅰ型胶原蛋白、牛骨Ⅰ型胶原蛋白、鱼皮蛋白包埋的12孔板中,常规培养,待细胞汇集率达到95%以上时,弃去培养基,无血清培养基饥饿培养12~16h;采用10微升移液器吸头,直尺比照划痕,PBS洗涤脱落细胞,10倍镜下计数划痕内细胞数,24h后再次测量划痕内的细胞数,每组随机取6个视野,用于后续统计学分析。实验重复3次。Scratch test using an inverted microscope to observe cell growth and morphological changes. Scratch method to detect the effect of different collagens on the migration of human fibroblasts Human fibroblasts from the 3rd to 6th passages were inoculated in 12 wells embedded with rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen, and fish skin protein In the plate, conventional culture, when the cell confluence rate reaches above 95%, discard the medium, starvation culture in serum-free medium for 12 to 16 hours; use a 10 microliter pipette tip, compare scratches with a ruler, and wash off with PBS Cells, the number of cells in the scratch was counted under a 10-fold microscope, and the number of cells in the scratch was measured again after 24 hours. Six fields of view were randomly selected for each group for subsequent statistical analysis. The experiment was repeated three times.

1.4统计学处理所有结果均采用SPSS 13.0软件进行统计学分析。实验结果采用表示,组间差异采用单因素方差分析,P<0.05为差异具有统计学意义。1.4 Statistical analysis All results were analyzed statistically using SPSS 13.0 software. Experimental results using The difference between groups was analyzed by one-way analysis of variance, and P<0.05 was considered statistically significant.

2结果2 results

2.1人成纤维细胞形态学观察倒置显微镜观察细胞形态,划痕实验24小时后,本发明品处理的六孔板划痕内细胞数量明显大于牛骨Ⅰ型胶原蛋白和鱼皮蛋白处理细胞培养板(P<0.05)。2.1 Morphological observation of human fibroblasts Observe the cell morphology with an inverted microscope. After 24 hours of scratch experiment, the number of cells in the scratch of the six-hole plate treated with the product of the present invention is significantly greater than that of the cell culture plate treated with bovine bone type Ⅰ collagen and fish skin protein (P<0.05).

表4包埋细胞划痕实验结果 Table 4 Results of scratch experiment on embedded cells

*与本发明大鼠尾Ⅰ型胶原蛋白相比P<0.05*P<0.05 compared with rat tail type Ⅰ collagen of the present invention

3结论3 Conclusion

和牛骨Ⅰ型胶原蛋白以及鱼皮蛋白相比,本发明大鼠尾Ⅰ型胶原蛋白更有利于人皮肤成纤维细胞的迁移,证明本发明大鼠尾Ⅰ型胶原蛋白有利于皮肤的修复。Compared with bovine bone type I collagen and fish skin protein, the rat tail type I collagen of the present invention is more conducive to the migration of human skin fibroblasts, which proves that the rat tail type I collagen of the present invention is beneficial to skin repair.

二、大鼠尾Ⅰ型胶原蛋白的皮肤美白功能验证性实验:2. Validation experiment of skin whitening function of rat tail type Ⅰ collagen:

1材料与方法1 Materials and methods

1.1主要仪器设备1.1 Main instruments and equipment

实验用主要仪器设备。(见表5)The main equipment used in the experiment. (See Table 5)

表5实验用主要仪器设备一览表Table 5 List of main instruments and equipment used in the experiment

1.2主要试剂1.2 Main reagents

主要试剂见表6.The main reagents are listed in Table 6.

表6主要检测试剂一览表Table 6 List of main detection reagents

1.3实验方法1.3 Experimental method

1.3.1小鼠黑色素瘤细胞培养及处理1.3.1 Culture and treatment of mouse melanoma cells

小鼠黑色素瘤细胞的培养根据国家实验细胞资源共享平台所提供的细胞培养指南进行,用含10%FBS的DMEM-H培养基培养于37℃、5%CO2的细胞培养箱中,待贴壁细胞密度达到90%左右时,用0.05%Trypsin-EDTA消化细胞,500g离心后,用完全培养基重悬细胞,1:3进行传代,3天传代1次。The culture of mouse melanoma cells was carried out according to the cell culture guidelines provided by the National Experimental Cell Resource Sharing Platform, cultured in DMEM-H medium containing 10% FBS in a cell culture incubator at 37°C and 5% CO2 , to be posted When the parietal cell density reaches about 90%, digest the cells with 0.05% Trypsin-EDTA, centrifuge at 500g, resuspend the cells in complete medium, passage at a ratio of 1:3, once every 3 days.

取对数生长期细胞消化后,对细胞进行计数,按1×103、1×104、1×105个细胞分别接种于96孔板、24孔板、6孔板,采用正常培养基培养24h后,用稀释至暴露终浓度的试剂加入培养体系,大鼠尾Ⅰ型胶原蛋白、牛骨Ⅰ型胶原蛋白和鱼皮蛋白的最终质量浓度分别为8mg/mL、4mg/mL、2mg/mL、1mg/mL、0.5mg/mL、0.25mg /mL每一浓度设4个孔,对照组不加大鼠尾Ⅰ型胶原蛋白,孵育72h。进行相关的实验操作。After the cells in the logarithmic growth phase were digested, the cells were counted, and 1×10 3 , 1×10 4 , and 1×10 5 cells were inoculated in 96-well plates, 24-well plates, and 6-well plates, respectively, using normal medium After culturing for 24 hours, the reagents diluted to the final exposure concentration were added to the culture system. The final mass concentrations of rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein were 8 mg/mL, 4 mg/mL, and 2 mg/mL, respectively. 4 wells were set for each concentration of mL, 1mg/mL, 0.5mg/mL, and 0.25mg/mL, and the control group was incubated for 72 hours without adding rat tail type Ⅰ collagen. Carry out related experiments.

1.3.2细胞增殖抑制率1.3.2 Cell proliferation inhibition rate

接种培养瓶同时,将其余部分接种于96孔细胞培养板,7组,每组5孔,每孔 100μL,37℃培养箱静置培养;培养24h后,向每孔内加入用磷酸缓冲液配制的0.5%MTT (5mg/mL)20uL,37℃培养箱内培育;4h后终止培养,将孔内培养液小心吸出。每孔加入150μL二甲基亚砜,置摇床上低速振荡10min,使结晶物充分溶解。同时每行第一孔设置为调零孔(培养基、MTT、二甲基亚砜)。用酶标仪OD570nm处测量各孔吸光值;黑色素细胞增殖抑制率=(1一各浓度平均吸光度值÷对照组平均吸光度值)×100%。At the same time of inoculating the culture flask, inoculate the rest in 96-well cell culture plates, 7 groups, 5 wells in each group, 100 μL per well, and culture in a 37°C incubator; after culturing for 24 hours, add phosphate buffer solution to each well 0.5% MTT (5mg/mL) 20uL, cultivated in a 37°C incubator; after 4 hours, the culture was terminated, and the culture solution in the well was carefully aspirated. Add 150 μL of dimethyl sulfoxide to each well, shake on a shaker at low speed for 10 minutes, and fully dissolve the crystals. At the same time, the first well of each row is set as the zero well (medium, MTT, dimethyl sulfoxide). Measure the absorbance value of each well at OD570nm with a microplate reader; melanocyte proliferation inhibition rate=(1-average absorbance value of each concentration÷average absorbance value of the control group)×100%.

1.3.3酪氨酸酶活力测定:1.3.3 Determination of tyrosinase activity:

大鼠尾Ⅰ型胶原蛋白、牛骨Ⅰ型胶原蛋白和鱼皮蛋白的最终质量浓度分别为8mg /mL、4mg/mL、2mg/mL、1mg/mL、0.5mg/mL、0.25mg/mL每一浓度设4 个孔,对照组不加大鼠尾Ⅰ型胶原蛋白,孵育72h。弃去上清液,用pH6.8PBS冲洗两遍,每孔加90μL含1%(体积分数)TritonX-100的PBS。冰浴中超声破碎,每孔加10μL 1×10-2moL/L的L-dopa,37℃孵育60min,用490nm波长比色,空白孔调零,测各孔吸光度值。酪氨酸酶活性抑制率=(1一各浓度平均吸光度值÷对照组平均吸光度值)×100%。The final mass concentrations of rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein were 8 mg/mL, 4 mg/mL, 2 mg/mL, 1 mg/mL, 0.5 mg/mL and 0.25 mg/mL, respectively. Set 4 wells at one concentration, and in the control group, rat tail type Ⅰ collagen was not added, and incubated for 72 hours. The supernatant was discarded, washed twice with pH6.8 PBS, and 90 μL of PBS containing 1% (volume fraction) TritonX-100 was added to each well. Sonicate in an ice bath, add 10 μL of 1×10 -2 moL/L L-dopa to each well, incubate at 37°C for 60 min, use 490 nm wavelength for colorimetry, set the blank well to zero, and measure the absorbance value of each well. Inhibition rate of tyrosinase activity=(1—average absorbance value of each concentration÷average absorbance value of control group)×100%.

1.3.4黑色素含量测定:1.3.4 Determination of melanin content:

小鼠黑色素瘤细胞以1×105个/mL的密度接种于3个6孔板。二氧化碳培养箱中孵育24小时后,把大鼠尾Ⅰ型胶原蛋白、牛骨Ⅰ型胶原蛋白和鱼皮蛋白培养液,浓度梯度一致,浓度分别为8mg/mL、4mg/mL、2mg/mL、1mg/mL、0.5mg/mL、 0.25mg/mL,染毒3天,弃上清液,PBS洗涤,每孔加入0.5mL胰酶消化,定容然后细胞计数。剩余细胞悬液1500r/min离心10mln,弃上清液,加入200微升蒸馏水和体积比为1:1的乙醇、乙醚混合液(除去一些不透明物质),摇匀,室温放置15分钟,3000r/min离心5分钟。弃上清液,于沉淀中加入1mL含10%(质量分数)DMSO 的1mol/L NaOH水溶液。80℃加热30min(具塞),选择490纳米波长在酶联免疫检测仪上测吸光度值。黑色素细胞生长率=(药物孔细胞密度÷对照孔细胞密度)×100%,黑色素合成抑制率=[1一(药物孔吸光度值÷药物孔细胞密度)÷(对照孔吸光度值÷对照孔细胞密度)]×100%。Mouse melanoma cells were seeded in three 6-well plates at a density of 1×105 cells/mL. After incubating in the carbon dioxide incubator for 24 hours, add rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein culture solution with the same concentration gradient, the concentrations are 8mg/mL, 4mg/mL, 2mg/mL, 1mg/mL, 0.5mg/mL, 0.25mg/mL, exposure for 3 days, discard the supernatant, wash with PBS, add 0.5mL trypsin to each well, constant volume and count the cells. Centrifuge the remaining cell suspension at 1500r/min for 10mln, discard the supernatant, add 200 microliters of distilled water and a mixture of ethanol and ether with a volume ratio of 1:1 (to remove some opaque substances), shake well, and place at room temperature for 15 minutes, 3000r/min min Centrifuge for 5 minutes. The supernatant was discarded, and 1 mL of 1 mol/L NaOH aqueous solution containing 10% (mass fraction) DMSO was added to the precipitate. Heat at 80° C. for 30 minutes (with a stopper), and select a wavelength of 490 nanometers to measure the absorbance value on an enzyme-linked immunosorbent assay instrument. Melanocyte growth rate=(drug well cell density ÷ control well cell density) × 100%, melanin synthesis inhibition rate=[1-(drug well absorbance value ÷ drug well cell density) ÷ (control well absorbance value ÷ control well cell density )] × 100%.

2结果:2 results:

2.1小鼠黑色素瘤细胞增殖2.1 Proliferation of mouse melanoma cells

大鼠尾Ⅰ型胶原蛋白,牛骨Ⅰ型胶原蛋白、鱼皮蛋白各剂量组对小鼠黑色素瘤细胞增殖未见抑制效应。见表7。Rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein had no inhibitory effect on the proliferation of mouse melanoma cells. See Table 7.

表7小鼠黑色素瘤细胞增殖抑制率测定Table 7 Determination of mouse melanoma cell proliferation inhibition rate

2.4大鼠尾Ⅰ型胶原蛋白,牛骨Ⅰ型胶原蛋白、鱼皮蛋白对酪氨酸酶活性的影响:2.4 Effects of rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein on tyrosinase activity:

大鼠尾Ⅰ型胶原蛋白,牛骨Ⅰ型胶原蛋白、鱼皮蛋白各剂量组对小鼠黑色素瘤细胞酪氨酸酶活性的具有明显的抑制作用,呈现剂量-反应关系。当剂量大于等于0.5 mg/mL时,在同等剂量水平,牛骨Ⅰ型胶原蛋白和鱼皮蛋白对络氨酸酶活性抑制率明显低于大鼠尾Ⅰ型胶原蛋白。见表8。Each dose group of rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein has obvious inhibitory effect on tyrosinase activity of mouse melanoma cells, showing a dose-response relationship. When the dose was greater than or equal to 0.5 mg/mL, at the same dose level, the inhibition rate of bovine bone type Ⅰ collagen and fish skin protein on tyrosinase activity was significantly lower than that of rat tail type Ⅰ collagen. See Table 8.

表8酪氨酸酶活性的影响 The impact of table 8 tyrosinase activity

*表示同浓度下本品相比P<0.05* means P<0.05 compared with this product at the same concentration

2.5大鼠尾Ⅰ型胶原蛋白,牛骨Ⅰ型胶原蛋白、鱼皮蛋白包埋对黑色素合成的影响2.5 Effect of rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein embedding on melanin synthesis

大鼠尾Ⅰ型胶原蛋白,牛骨Ⅰ型胶原蛋白、鱼皮蛋白各剂量组对小鼠黑色素瘤细胞黑色素水平具有明显的抑制作用,呈现剂量-反应关系。当剂量大于等于0.5mg/ml 时,在同等剂量水平,牛骨Ⅰ型胶原蛋白和鱼皮蛋白对络氨酸酶活性抑制率明显低于大鼠尾Ⅰ型胶原蛋白。见表9。Each dose group of rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein has a significant inhibitory effect on the melanin level of mouse melanoma cells, showing a dose-response relationship. When the dose is greater than or equal to 0.5mg/ml, at the same dose level, the inhibition rate of bovine bone type Ⅰ collagen and fish skin protein on tyrosinase activity is significantly lower than that of rat tail type Ⅰ collagen. See Table 9.

表9大鼠尾Ⅰ型胶原蛋白对黑色素的影响 Table 9 Effect of rat tail type Ⅰ collagen on melanin

*表示同浓度下本品相比P<0.05* means P<0.05 compared with this product at the same concentration

结论:本发明大鼠尾Ⅰ型胶原蛋白、牛骨Ⅰ型胶原蛋白和鱼皮蛋白相比美白效果更佳。Conclusion: Compared with rat tail type Ⅰ collagen, bovine bone type Ⅰ collagen and fish skin protein, the whitening effect is better.

实施例2、大鼠尾Ⅰ型胶原蛋白的皮肤、眼睛、遗传毒性实验Embodiment 2, skin, eyes, genotoxicity test of rat tail type Ⅰ collagen

一、急性皮肤刺激性试验1. Acute skin irritation test

按照《化妆品卫生规范》(2007年版)进行如下实验:Carry out the following experiments according to "Hygienic Standards for Cosmetics" (2007 edition):

材料和方法:Materials and methods:

1、受试物:大鼠尾Ⅰ型胶原蛋白(同本实施例1中配方及方法制备)1. Test substance: rat tail type Ⅰ collagen (prepared with the formula and method in Example 1)

2、动物和饲养环境:新西兰种家兔,普通级,由,共4只,体重为2-3kg。北京金牧阳实验动物养殖有限责任公司[许可证号:SCXK(京)2015-0005]。动物饲养地点:中国疾病控制中心动物房(许可证号:SYXK(京)2014-0043);动物房的温度为20-25℃,湿度为40-50%RH。动物饲料购自北京华阜康生物科技股份有限公司(许可证号: SCXK(京)2014-0008),饮水为纯净水。2. Animals and breeding environment: New Zealand rabbits, common grade, 4 in total, weighing 2-3kg. Beijing Jinmuyang Experimental Animal Breeding Co., Ltd. [license number: SCXK (Beijing) 2015-0005]. Animal breeding location: animal room of China Center for Disease Control (permit number: SYXK (Beijing) 2014-0043); the temperature of the animal room is 20-25° C., and the humidity is 40-50% RH. Animal feed was purchased from Beijing Huafukang Biotechnology Co., Ltd. (permit number: SCXK (Beijing) 2014-0008), and drinking water was purified water.

3、试验方法:试验前约24h,将动物背部脊柱两侧毛剪掉,去毛范围左、右各约 3cm×3cm。取受试物大鼠尾Ⅰ型胶原蛋白各约0.5直接涂在2.5cm×2.5cm皮肤上,然后用二层纱布和一层玻璃纸覆盖,再用无刺激性胶布和绷带加以固定。另一侧皮肤作为对照。敷用时间为h。然后用清冼以除去残留受试物。于清除受试物后的1h、24h、 48h、72h及第4、5、6日观察涂抹部位的皮肤反应,按《化妆品卫生规范》(2007年版)“皮肤刺激性/腐蚀性试验”中标准进行皮肤反应评分,根据24、48和72小时各观察时点最高积分均值,按其中标准判定皮肤刺激强度。3. Test method: About 24 hours before the test, cut off the hair on both sides of the back and spine of the animal, and the left and right sides of the hair removal range are about 3cm×3cm. Take about 0.5 of the rat tail type Ⅰ collagen of the test substance and apply it directly on the skin of 2.5cm×2.5cm, then cover it with two layers of gauze and a layer of cellophane, and then fix it with non-irritating adhesive tape and bandage. The skin on the other side served as a control. The application time is h. Then wash to remove residual test substance. 1h, 24h, 48h, 72h and the 4th, 5th, and 6th day after removing the test substance, observe the skin reaction of the application site, according to the standard in "Skin Irritation/Corrosion Test" in "Hygienic Standards for Cosmetics" (2007 Edition) Carry out the skin reaction score, and judge the intensity of skin irritation according to the highest integral mean value at each observation time point of 24, 48 and 72 hours according to the standard.

试验结果:如表10所示。Test results: as shown in Table 10.

表10大鼠尾Ⅰ型胶原蛋白对家兔急性皮肤刺激性试验结果Table 10 Acute skin irritation test results of rat tail type Ⅰ collagen to rabbits

由表10中结果可知,受试物对家兔急性皮肤刺激性为无刺激性。As can be seen from the results in Table 10, the test substance is non-irritating to the acute skin irritation of rabbits.

二、急性眼刺激性试验2. Acute eye irritation test

按照《化妆品卫生规范》(2007年版)进行如下实验:Carry out the following experiments according to "Hygienic Standards for Cosmetics" (2007 edition):

材料和方法:Materials and methods:

1、受试物:大鼠尾Ⅰ型胶原蛋白。1. Test substance: rat tail type Ⅰ collagen.

2、动物和饲养环境:新西兰家兔,普通级,北京金牧阳实验动物养殖有限责任公司[许可证号:SCXK(京)2015-0005],,共3只。体重为2-3kg。动物饲养地点:中国疾病控制中心动物房(许可证号:SYXK(京)2014-0043);动物房的温度为20~25℃,湿度为40~50%RH。动物饲料购自北京华阜康生物科技股份有限公司(许可证号: SCXK(京)2014-0008),饮水为纯净水。2. Animals and breeding environment: New Zealand rabbits, ordinary grade, Beijing Jinmuyang Experimental Animal Breeding Co., Ltd. [license number: SCXK (Beijing) 2015-0005], a total of 3 rabbits. The body weight is 2-3kg. Animal breeding location: animal room of China Center for Disease Control (permit number: SYXK (Beijing) 2014-0043); the temperature of the animal room is 20-25° C., and the humidity is 40-50% RH. Animal feed was purchased from Beijing Huafukang Biotechnology Co., Ltd. (permit number: SCXK (Beijing) 2014-0008), and drinking water was purified water.

3、试验方法:试验前24h对家兔两眼进行检查,所选动物均为无眼刺激症状、角膜缺陷及结膜损伤。试验时将受试物约0.1ml分别滴入3只家兔右眼结膜囊中,使上、下眼睑被动闭合1s,至第4s用足量、流速较快的生理盐水冲洗30s。左眼同样处理作自身对照。于染毒后1h、24h、48h、72h和第4、7天对动物眼睛进行检查,按《化妆品卫生规范》(2007年版)“急性眼刺激性/腐蚀性试验”中标准进行眼刺激反应评分,按其中标准进行眼刺激性反应分级。3. Test method: The eyes of the rabbits were checked 24 hours before the test, and all the selected animals had no symptoms of eye irritation, corneal defects and conjunctival damage. During the test, about 0.1ml of the test substance was dripped into the conjunctival sacs of the right eyes of 3 rabbits, and the upper and lower eyelids were passively closed for 1 second, and rinsed with a sufficient amount of normal saline at a faster flow rate for 30 seconds in the 4th second. The left eye was treated in the same way as its own control. Animal eyes were inspected at 1h, 24h, 48h, 72h and 4th and 7th days after exposure, and the eye irritation reaction scores were scored according to the standard in "Acute Eye Irritation/Corrosion Test" in "Hygienic Standards for Cosmetics" (2007 Edition) , according to the standard for eye irritation classification.

试验结果:如表11所示。Test results: as shown in Table 11.

表11受试物对家兔急性眼刺激性试验结果 30s冲洗Table 11 Test substance to rabbit acute eye irritation test result 30s flushing

由表11中结果可知,受试物大鼠尾Ⅰ型胶原蛋白对家兔急性眼刺激性试验结果为无刺激性。From the results in Table 11, it can be seen that the test substance rat tail type Ⅰ collagen is non-irritating to rabbits in the acute eye irritation test.

三、皮肤光毒性试验3. Skin phototoxicity test

按照《化妆品卫生规范》(2007年版)进行如下实验:Carry out the following experiments according to "Hygienic Standards for Cosmetics" (2007 edition):

材料和方法:Materials and methods:

1、受试物:大鼠尾Ⅰ型胶原蛋白1. Test substance: rat tail type Ⅰ collagen

2、阳性物:0.005%8-甲氧基补骨脂。2. Positive substance: 0.005% 8-methoxypsoralen.

3、动物和饲养环境:白化豚鼠,普通级,北京金牧阳实验动物养殖有限责任公司[许可证号:SCXK(京)2015-0005],共6只。体重为雌性220-260g,雄性230-280g。动物饲养地点:中国疾病控制中心动物房(许可证号:SYXK(京)2014-0043);动物房的温度为20-25℃,湿度为40-50%RH。动物饲料购自北京华阜康生物科技股份有限公司(许可证号:SCXK(京)2014-0008),饮水为纯净水。3. Animals and breeding environment: Albino guinea pigs, ordinary grade, Beijing Jinmuyang Experimental Animal Breeding Co., Ltd. [license number: SCXK (Beijing) 2015-0005], 6 in total. The body weight is 220-260g for females and 230-280g for males. Animal breeding location: animal room of China Center for Disease Control (permit number: SYXK (Beijing) 2014-0043); the temperature of the animal room is 20-25° C., and the humidity is 40-50% RH. Animal feed was purchased from Beijing Huafukang Biotechnology Co., Ltd. (permit number: SCXK (Beijing) 2014-0008), and drinking water was purified water.

4、试验方法:UV光源:美国GE公司产品,直径为38mm,功率40W,波长 350-400nm的黑光灯管。UVB<0.1J/cm24. Test method: UV light source: a black light tube with a diameter of 38mm, a power of 40W, and a wavelength of 350-400nm, produced by GE in the United States. UVB<0.1J/cm 2 .

试验前18-24h,于豚鼠脊柱两侧备4块(编号为1、2、3、4)去毛区,每块去毛面积约为2cm×2cm,1、3位于左侧,2、4位于右侧。实验时,将动物固定在特制的木板上,将受试物约0.2g涂在去毛区1、2上,3、4不涂受试物。涂受试物30min后将1、 3区用铝箔纸覆盖,胶带固定,2、4区用UV光源进行照射。照射结束后分别于1、 24、48和72h观察皮肤反应,根据《化妆品卫生规范》(2007年版)中“皮肤光毒性试验”中标准判定每只动物反应评分。18-24 hours before the test, prepare 4 pieces (numbered 1, 2, 3, 4) on both sides of the guinea pig's spine for hair removal. The hair removal area of each piece is about 2cm × 2cm. on the right. During the experiment, the animals were fixed on a special wooden board, and about 0.2 g of the test substance was applied to the depilated areas 1 and 2, and no test substance was applied to the 3 and 4 areas. After 30 minutes of applying the test substance, cover areas 1 and 3 with aluminum foil and fix them with adhesive tape, and irradiate areas 2 and 4 with a UV light source. The skin reaction was observed at 1, 24, 48 and 72 hours after the irradiation, and the reaction score of each animal was judged according to the standard in "Skin Phototoxicity Test" in "Hygienic Standards for Cosmetics" (2007 edition).

光强度平均值:2.57mW/cm2;照射时间按下式计算为65min。The average light intensity: 2.57mW/cm 2 ; the irradiation time is calculated as 65min according to the following formula.

实验结果:如表12所示。Experimental results: as shown in Table 12.

表12受试物对豚鼠皮肤光毒性试验结果Table 12 Test substance to guinea pig skin phototoxicity test result

注:1,2,3,4为《化妆品卫生规范》(2007年)第二部分七、皮肤光毒性试验之中所示试验区。Note: 1, 2, 3, and 4 are the test areas shown in Part II of "Hygienic Standards for Cosmetics" (2007), Part VII, Skin Phototoxicity Test.

表13阳性物对豚鼠皮肤光毒性试验结果Table 13 Positives are to guinea pig skin phototoxicity test result

注:1,2,3,4为《化妆品卫生规范》(2007年)第二部分七、皮肤光毒性试验之中所示试验区。阳性对照组试验日期为2018年2月1日至2019年3月10日。Note: 1, 2, 3, and 4 are the test areas shown in Part II of "Hygienic Standards for Cosmetics" (2007), Part VII, Skin Phototoxicity Test. The test period of the positive control group was from February 1, 2018 to March 10, 2019.

由上述实验结果可知,该受试物大鼠尾Ⅰ型胶原蛋白对豚鼠皮肤光毒性试验结果为阴性。From the above experimental results, it can be known that the phototoxicity test of the test substance rat tail type I collagen on guinea pig skin was negative.

四、皮肤变态反应试验4. Skin allergy test

材料和方法:Materials and methods:

1、细胞株:中国仓鼠卵巢(CHO)细胞株。1. Cell line: Chinese hamster ovary (CHO) cell line.

2、代谢活化系统:使用经苯巴比妥钠和β-萘黄酮联合诱导的大鼠肝匀浆并加相应的辅助因子配制成的混合物作为体外代谢活化系统(S9mix)。2. Metabolic activation system: a mixture prepared by combining rat liver homogenate induced by phenobarbital sodium and β-naphthoflavone and adding corresponding cofactors was used as the in vitro metabolic activation system (S 9 mix).

3、受试物:大鼠尾Ⅰ型胶原蛋白用不含血清的DMEM培养液稀释后用于试验。3. Test substance: Rat tail type Ⅰ collagen was diluted with serum-free DMEM culture solution and used for the test.

4、试验方法:4. Test method:

(1)培养液:DMEM培养液加入10%胎牛血清及100IU/ml的青、链霉素。(1) Culture medium: 10% fetal bovine serum and 100 IU/ml penicillin and streptomycin were added to DMEM culture medium.

(2)最高终浓度确定:试验设受试物组及阴性对照组。将CHO细胞接种于直径为6cm的培养皿中,接种密度为1.2×106/皿,37℃,5%CO2培养24h后,吸去培养皿中培养液,加入不同浓度的受试物及不含血清的培养液,代谢活化组同时加入S9mix,放培养箱中作用3h后,弃去含受试物的培养液,用D-hanks液洗细胞3次,加入含 10%胎牛血清的培养液,继续培养24h,阴性对照组仅加培养液(代谢活化组同时加入S9)。在倒置显微镜下观察各平皿细胞的生长情况,根据细胞覆盖程度的改变确定试验时受试物的最高终浓度。(2) Determination of the highest final concentration: the test set up a test substance group and a negative control group. CHO cells were inoculated in a culture dish with a diameter of 6 cm at a seeding density of 1.2×10 6 /dish. After culturing for 24 hours at 37°C and 5% CO 2 , the culture medium in the culture dish was sucked off, and different concentrations of test substances and Serum-free culture solution, metabolic activation group was added with S 9 mix at the same time, placed in the incubator for 3 hours, the culture solution containing the test substance was discarded, the cells were washed with D-hanks solution for 3 times, and 10% fetal bovine The serum culture solution was continued to be cultured for 24 hours, and only the culture solution was added to the negative control group (S 9 was added to the metabolic activation group at the same time). Observe the growth of the cells in each plate under an inverted microscope, and determine the highest final concentration of the test substance during the test according to the change in the degree of cell coverage.

(3)染色体畸变试验:试验在加和不加代谢活化系统条件下进行。设受试物组、阴性对照组和阳性对照组。根据预试验结果,受试物组的终浓度设定为250、125和 62.5μg/mL(-S9),及2000、1000和500μg/mL(+S9)。按照与预试验相同的处理方法分别加入受试物,作用3h后换液,继续培养24h收获细胞。收获前4h加入秋水仙素,终浓度为1.0μg/mL。按常规方法消化,低渗,固定,制片,Giemsa染色。对各受试物组、阴性对照组和阳性对照组选取100个分散良好的中期分裂相细胞,进行染色体畸变分析。记录染色体结构畸变的类型和数目,并计算染色体畸变率。(3) Chromosomal aberration test: the test was carried out with and without the metabolic activation system. Set up test substance group, negative control group and positive control group. According to the preliminary test results, the final concentrations of the test substance groups were set at 250, 125 and 62.5 μg/mL (-S 9 ), and 2000, 1000 and 500 μg/mL (+S 9 ). The test substances were added according to the same treatment method as the pre-test, the medium was changed after 3 hours of action, and the cells were harvested after continuing to culture for 24 hours. Colchicine was added 4 hours before harvest to a final concentration of 1.0 μg/mL. Digestion, hypotonicity, fixation, slide preparation and Giemsa staining were performed according to conventional methods. For each test substance group, negative control group and positive control group, 100 well-dispersed metaphase cells were selected for chromosome aberration analysis. Record the type and number of chromosomal structural aberrations, and calculate the chromosomal aberration rate.

统计学分析:用χ2检验将各受试物组细胞的染色体畸变率与阴性对照组进行比较,确定是否有显著性差异。Statistical analysis: χ 2 test was used to compare the chromosomal aberration rate of cells in each test group with the negative control group to determine whether there was a significant difference.

试验结果:test results:

表14体外哺乳动物细胞染色体畸变试验结果(-S9)Table 14 In vitro mammalian cell chromosome aberration test results (-S 9 )

*P<0.01*P<0.01

表15体外哺乳动物细胞染色体畸变试验结果(+S9)Table 15 In vitro mammalian cell chromosome aberration test results (+S 9 )

*P<0.01*P<0.01

由上述实验结果可知,在本实验条件下,该样品在对体外培养的哺乳动物中国仓鼠卵巢细胞(CHO)染色体畸变检测系统中,与阴性对照组相比,无论是否加入活化系统,大鼠尾Ⅰ型胶原蛋白均未引起染色体畸变率的明显增加,故在此测试系统中未呈现致突变性。From the above experimental results, it can be seen that under the experimental conditions, the sample in the in vitro cultured mammalian Chinese hamster ovary cell (CHO) chromosome aberration detection system, compared with the negative control group, no matter whether the activation system was added, the rat tail Type Ⅰ collagen did not cause a significant increase in the chromosomal aberration rate, so it did not exhibit mutagenicity in this test system.

实施例3、大鼠尾Ⅰ型胶原蛋白毒理学试验Embodiment 3, rat tail type Ⅰ collagen toxicological test

1材料和方法1 Materials and methods

1.1样品:大鼠尾Ⅰ型胶原蛋白为无色透明果冻状胶体。1.1 Sample: Rat tail type Ⅰ collagen is a colorless transparent jelly-like colloid.

1.2实验动物和饲养条件:动物:选用北京华阜康生物科技股份有限公司提供的SD大鼠(清洁级,合格证号:SYXK(京)2014-0004)。饲养地点:中国疾病控制中心动物房(许可证号:SYXK(京)2014-0043);饲料:购自北京华阜康生物科技股份有限公司(许可证号:SCXK(京)2014-0004)。1.2 Experimental animals and feeding conditions: Animals: SD rats (clean grade, certificate number: SYXK (Beijing) 2014-0004) provided by Beijing Huafukang Biotechnology Co., Ltd. were selected. Breeding place: animal room of China Center for Disease Control (permit number: SYXK (Beijing) 2014-0043); feed: purchased from Beijing Huafukang Biotechnology Co., Ltd. (permit number: SCXK (Beijing) 2014-0004).

1.3主要仪器与试剂:BECKMAN GS15R离心机(608112);日立7080型自动生化仪(060817);BECKMAN COULTER Ac.T diff2TM血液分析仪(060816);NIKON生物显微镜(608105);VIP-E150F全自动脱水机(630125),TEK-CC/TEK-EC全自动包埋机(630122),E0106半自动石蜡切片机(630121),ST5010全自动染色机(630127), SCA-5600全自动封片机(630126)。库尔特电解质平衡液和库尔特溶血剂购自贝克曼库尔特实验系统(苏州)有限公司;血生化检测试剂盒购自中生北控生物科技股份有限公司。1.3 Main instruments and reagents: BECKMAN GS15R centrifuge (608112); Hitachi 7080 automatic biochemical analyzer (060817); BECKMAN COULTER A c .T diff2 TM blood analyzer (060816); NIKON biological microscope (608105); Automatic dehydrator (630125), TEK-CC/TEK-EC automatic embedding machine (630122), E0106 semi-automatic paraffin slicer (630121), ST5010 automatic dyeing machine (630127), SCA-5600 automatic sealing machine ( 630126). Coulter electrolyte balance solution and Coulter hemolysis reagent were purchased from Beckman Coulter Experimental System (Suzhou) Co., Ltd.; blood biochemical detection kits were purchased from Zhongsheng Beikong Biotechnology Co., Ltd.

1.4实验方法:1.4 Experimental method:

1.4.1大鼠急性毒性试验:采用最大耐受量法(MTD)进行。选用健康SD大鼠20 只(雌雄各10只)进行试验。大鼠体重为180-210克。45g受试物用蒸馏水溶至180ml (浓度为0.25g/ml),以20ml/kgBW灌胃量进行灌胃,一日3次,即急性毒性剂量为15g/kg BW,灌胃后连续观察14天。记录动物中毒表现及死亡情况。1.4.1 Rat acute toxicity test: the maximum tolerated dose method (MTD) was used. 20 healthy SD rats (10 male and 10 each) were selected for the experiment. Rats weighed 180-210 grams. 45g test substance was dissolved to 180ml (concentration is 0.25g/ml) with distilled water, carried out intragastric administration with 20ml/kgBW intragastric administration, 3 times a day, namely the acute toxicity dose was 15g/kg BW, observed continuously for 14 days after intragastric administration. sky. Animal poisoning performance and death were recorded.

1.4.2遗传毒性试验:1.4.2 Genotoxicity test:

1.4.2.1 Ames试验:采用经鉴定符合要求的鼠伤寒沙门氏菌组氨酸缺陷型TA97、TA98、TA100、TA102四株试验菌株进行试验。采用多氯联苯(PCB)诱导的大鼠肝匀浆制作的S-9作为活化系统。根据毒性测定结果,试验设0.313、0.625、1.250、2.500、 5.000mg/皿5个剂量,将1g受试物用紫外线消毒后以无菌水溶解定容至20ml作为最高剂量(5.0mg/皿浓度),其余剂量以无菌水2倍倍比稀释,加样量均为100μL/皿。同时设未处理对照、溶剂对照和阳性对照皿。在顶层琼脂中加入0.1ml试验菌株增菌液、0.1ml受试物溶液和0.5ml S-9混合液(当需要代谢活化时),混匀后倒入底层培养基平板上。在37℃培养48h,计数每皿回变菌落数。如果受试物的回变菌落数是溶剂对照菌落数2倍以上,并具有剂量-反应关系者则定为阳性。整个试验在相同条件下重复做一次。1.4.2.1 Ames test: Four test strains of Salmonella typhimurium TA97, TA98, TA100 and TA102, which have been identified and meet the requirements, are used for the test. S-9 prepared from rat liver homogenate induced by polychlorinated biphenyls (PCB) was used as the activation system. According to the toxicity determination result, test is set 0.313, 0.625, 1.250, 2.500, 5.000mg/dish 5 doses, after 1g test substance is sterilized with ultraviolet ray, is dissolved in aseptic water and is settled to 20ml as highest dose (5.0mg/dish concentration ), and the remaining doses were diluted 2-fold with sterile water, and the sample volume was 100 μL/dish. At the same time set up untreated control, solvent control and positive control dishes. Add 0.1ml test strain enrichment solution, 0.1ml test substance solution and 0.5ml S-9 mixed solution (when metabolic activation is required) to the top agar, mix well and pour it on the bottom medium plate. Incubate at 37°C for 48 hours, and count the number of reverted colonies per dish. If the number of reverted colonies of the test substance is more than 2 times the number of colonies of the solvent control, and there is a dose-response relationship, it is regarded as positive. The whole test was repeated under the same conditions.

1.4.2.2小鼠骨髓嗜多染红细胞微核试验:采用间隔24h两次经口灌胃法进行试验。选用体重25-30克小鼠50只,按体重随机分为5组,每组10只,雌雄各半。称取20g受试物用蒸馏水定溶至80ml作为高剂量,中、低剂量依次2倍倍比稀释,灌胃量均为 30ml/kgBW,即大鼠尾Ⅰ型胶原蛋白低、中、高剂量分别为1.88、3.75、7.50g/kgBW。以40mg/kgBW剂量的环磷酰胺为阳性对照,蒸馏水为阴性对照。末次给大鼠尾Ⅰ型胶原蛋白6h后颈椎脱臼处死动物,取胸骨骨髓用小牛血清稀释涂片,甲醇固定,Giemsa 染色。在生物学显微镜下,每只动物计数200个红细胞(RBC)中的嗜多染红细胞(PCE) 数,并计算其所占比例;每只动物计数1000个嗜多染红细胞,其微核发生率以含微核的PCE千分率计,并进行统计处理。1.4.2.2 Mice bone marrow polychromatic erythrocyte micronucleus test: The test was carried out by oral gavage twice at intervals of 24 hours. Fifty mice with a body weight of 25-30 grams were selected and randomly divided into 5 groups according to body weight, with 10 mice in each group, half male and half male. Weigh 20g of the test substance and dissolve it in distilled water to 80ml as the high dose, and then dilute the medium and low doses by 2 times. They are 1.88, 3.75, 7.50g/kgBW respectively. Cyclophosphamide at a dose of 40mg/kgBW was used as a positive control, and distilled water was used as a negative control. Six hours after the last administration of tail type Ⅰ collagen, the animals were sacrificed by cervical dislocation, and the sternal bone marrow was diluted with calf serum for smears, fixed with methanol, and stained with Giemsa. Under a biological microscope, count the number of polychromatic erythrocytes (PCE) in 200 red blood cells (RBC) per animal, and calculate its proportion; count 1000 polychromatic erythrocytes per animal, and the incidence of micronuclei It is calculated by the PCE percentage per thousand containing micronuclei, and statistically processed.

1.4.3 90天喂养试验:选用体重60-90g断乳大鼠80只,随机分为4组,即对照组和3个受试物组。称取20g受试物用蒸馏水定溶至80ml作为高剂量(为最大使用浓度),中、低剂量依次2倍倍比稀释,灌胃量均为10ml/kgBW。即高、中、低剂量分别为0.63、1.25、2.50g/kgBW,对照组灌胃给予蒸馏水。每组20只动物,雌雄各半。动物单笼喂养,自由饮食,每周称量两次大鼠体重,根据体重调整灌胃量。每周记录两次给食量、剩食和撒食量,连续观察90天,实验结束采血测各项血液学、血生化指标及病理组织学检查。1.4.3 90-day feeding test: Select 80 weaned rats weighing 60-90g and divide them into 4 groups at random, namely the control group and 3 test substance groups. Weigh 20g of the test substance and dissolve it in distilled water to 80ml as the high dose (being the maximum use concentration), and the medium and low doses are sequentially diluted by 2 times, and the gavage volume is 10ml/kgBW. That is, the high, medium and low doses were 0.63, 1.25, 2.50 g/kgBW respectively, and the control group was given distilled water by intragastric administration. There were 20 animals in each group, half male and half male. The animals were fed in a single cage, free to eat and drink, and the rats were weighed twice a week, and the amount of gavage was adjusted according to the body weight. Food intake, leftover food, and sprinkled food were recorded twice a week, and observed continuously for 90 days. At the end of the experiment, blood was collected to measure various hematology, blood biochemical indicators, and histopathological examinations.

1.4.3.1观察指标:1.4.3.1 Observation indicators:

1.4.3.1.1动物的一般表现、体重、食物利用率1.4.3.1.1 Animal general performance, body weight, food utilization

1.4.3.1.2血常规及生化指标:白细胞计数及其分类、红细胞计数、血红蛋白、血小板计数;谷草转氨酶、谷丙转氨酶、碱性磷酸酶、尿素氮、肌酐、胆固醇、甘油三酯、血糖、总蛋白、白蛋白。1.4.3.1.2 Blood routine and biochemical indicators: white blood cell count and its classification, red blood cell count, hemoglobin, platelet count; aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, urea nitrogen, creatinine, cholesterol, triglyceride, blood sugar, Total Protein, Albumin.

1.4.3.1.3脏体比:实验结束处死动物取肝、肾、脾、心脏、胸腺和睾丸称重,计算相应的脏体比(以百克体重计算)。1.4.3.1.3 Visceral body ratio: the animals were sacrificed at the end of the experiment, and the liver, kidney, spleen, heart, thymus and testis were weighed to calculate the corresponding visceral body ratio (calculated in 100 grams of body weight).

1.4.3.1.4病理组织学:解剖进行大体观察及病理组织学检查。在对各剂量组动物做大体检查未发现明显病变和生化指标未见异常改变时,仅先对高剂量组和对照组动物进行心脏、肾上腺、胸腺、肝、肾、胃和十二指肠、脾、睾丸或卵巢病理观察。1.4.3.1.4 Histopathology: gross observation and histopathological examination by anatomy. When the general examination of the animals in each dose group did not find obvious lesions and abnormal changes in biochemical indicators, only the animals in the high-dose group and the control group were examined for heart, adrenal gland, thymus, liver, kidney, stomach and duodenum, Pathological observation of spleen, testis or ovary.

1.4.3.2统计方法:数据经SPSS10.O计算均数和标准差,并进行统计分析。1.4.3.2 Statistical method: The mean and standard deviation of the data are calculated by SPSS10.0, and statistical analysis is carried out.

2结果2 results

2.1大鼠急性毒性试验:由表1,6可见,经口灌胃给予雌、雄性大鼠15.0g/kgBW剂量的大鼠尾Ⅰ型胶原蛋白,观察14天后,未见明显的中毒症状,也无死亡,结果表明该受试物对雌、雄性大鼠的MTD大于15.0g/kgBW。2.1 Rat acute toxicity test: It can be seen from Tables 1 and 6 that female and male rats were given 15.0g/kgBW rat tail type Ⅰ collagen by oral gavage. There was no death, and the results showed that the MTD of the test substance to female and male rats was greater than 15.0g/kgBW.

表16大鼠尾Ⅰ型胶原蛋白大鼠急性毒性试验结果Table 16 rat tail type Ⅰ collagen rat acute toxicity test results

性别gender 初重(g)Initial weight (g) 终重(g)Final weight (g) MTD(g/kgBW)MTD (g/kgBW) female 194.6±5.8(185-206)194.6±5.8(185-206) 230.2±10.1(215-246)230.2±10.1(215-246) >15>15 male 196.2±6.8(182-210)196.2±6.8(182-210) 294.6±17.0(259-319)294.6±17.0(259-319) >15 >15

2.2遗传毒性试验:2.2 Genetic toxicity test:

2.2.1 Ames试验:由表17和表18可见,对照皿回变菌落数在正常范围,大鼠尾Ⅰ型胶原蛋白各剂量组回变菌落数均未超过溶剂对照菌落数2倍,亦无剂量-反应关系,故对鼠伤寒沙门氏菌TA97、TA98、TA100、TA102四株试验菌株,在加与不加S-9时,均未见大鼠尾Ⅰ型胶原蛋白有致基因突变作用。2.2.1 Ames test: It can be seen from Table 17 and Table 18 that the number of back-changing colonies in the control dish is within the normal range, and the number of back-changing colonies in each dosage group of rat tail type Ⅰ collagen does not exceed 2 times the number of solvent control colonies, nor does it Dose-response relationship, so for the four test strains of Salmonella typhimurium TA97, TA98, TA100, TA102, when adding or not adding S-9, there was no mutagenic effect on rat tail type Ⅰ collagen.

表17大鼠尾Ⅰ型胶原蛋白Ames试验第1次结果Table 17 The results of the first Ames test of rat tail type Ⅰ collagen

注:以上结果为三皿平均值Note: The above results are the average value of three dishes

表18大鼠尾Ⅰ型胶原蛋白Ames试验第2次结果Table 18 Results of the second Ames test of rat tail type Ⅰ collagen

注:以上结果为三皿平均值。Note: The above results are the average value of three dishes.

2.2.2小鼠骨髓嗜多染红细胞微核试验:由表19可见,各受试物剂量组嗜多染红细胞(PCE)百分比不少于阴性对照的20%,表明受试物在实验剂量下无细胞毒性;无论雄性还是雌性小鼠环磷酰胺阳性对照组微核发生率均明显高于阴性对照组和受试物各剂量组(泊松分布检验P<0.01),而受试物各剂量组与阴性对照组比较均无显著性差异 (P>0.05)。说明该受试物对小鼠体细胞染色体无致突变作用。2.2.2 Mouse bone marrow polychromatic erythrocyte micronucleus test: It can be seen from Table 19 that the percentage of polychromatic erythrocytes (PCE) in each test substance dosage group is not less than 20% of the negative control, indicating that the test substance is under the test dose. No cytotoxicity; no matter male or female mouse cyclophosphamide positive control group micronucleus incidence rate was significantly higher than negative control group and each dose group of test substance (Poisson distribution test P<0.01), while each dose of test substance There was no significant difference between the control group and the negative control group (P>0.05). It shows that the test substance has no mutagenic effect on mouse somatic chromosomes.

表19大鼠尾Ⅰ型胶原蛋白对小鼠骨髓微核发生率的影响Table 19 Effect of rat tail type Ⅰ collagen on the incidence of bone marrow micronuclei in mice

注:a:示与各受试物处理组比较,泊松分布统计P>0.05;Note: a : show that compared with each test substance treatment group, Poisson distribution statistics P>0.05;

b:示与各受试物处理组和阴性对照组比较,泊松分布统计P<0.01。 b : show that compared with each test substance treatment group and negative control group, Poisson distribution statistics P<0.01.

2.3 90天喂养试验:2.3 90-day feeding test:

2.3.1生长状况及食物利用率:2.3.1 Growth status and food utilization rate:

各组动物活动、生长正常,被毛浓密有光泽。由表20可见,以0.63、1.25、2.50g/kgBW 剂量的大鼠尾Ⅰ型胶原蛋白灌胃给予大鼠90天,各受试物剂量组动物体重、体重增重和总食物利用率与对照组比较均无显著性差异(P>0.05)。Animals in each group moved and grew normally, and their coats were thick and shiny. It can be seen from Table 20 that rat tail type Ⅰ collagen was given to rats by intragastric administration for 90 days with doses of 0.63, 1.25, and 2.50 g/kgBW. There was no significant difference between groups (P>0.05).

表20大鼠尾Ⅰ型胶原蛋白90天喂养试验对大鼠体重的影响 Table 20 Effect of rat tail type Ⅰ collagen feeding test on rat body weight in 90 days

2.3.2血常规及血生化指标:2.3.2 Blood routine and blood biochemical indicators:

由表21-22可见,以0.63、1.25、2.50g/kgBW剂量的大鼠尾Ⅰ型胶原蛋白灌胃给予大鼠90天,与对照组比较,雌雄各受试物剂量组的血常规与对照组比较均无显著性差异(P>0.05)。It can be seen from Table 21-22 that the rat tail type Ⅰ collagen of 0.63, 1.25, 2.50g/kgBW dosage was given to rats by intragastric administration for 90 days. There was no significant difference between groups (P>0.05).

表21大鼠尾Ⅰ型胶原蛋白90天喂养试验对大鼠中期血常规的影响 Table 21 Effect of 90-day feeding test of rat tail type Ⅰ collagen on rat mid-term blood routine

表22大鼠尾Ⅰ型胶原蛋白90天喂养试验对大鼠末期血常规的影响 Table 22 Effect of 90-day feeding test of rat tail type Ⅰ collagen on blood routine of rats

由表23-24可见,以0.63、1.25、2.50g/kgBW剂量的大鼠尾Ⅰ型胶原蛋白灌胃给予大鼠90天,与对照组比较各受试物剂量组的血生化指标与对照组比较均无显著性差异(P>0.05)。It can be seen from Table 23-24 that the rat tail type Ⅰ collagen of 0.63, 1.25, 2.50g/kgBW dosage was given to rats by intragastric administration for 90 days, and compared with the control group, the blood biochemical indicators of each test substance dosage group were compared with those of the control group. There was no significant difference between them (P>0.05).

表23大鼠尾Ⅰ型胶原蛋白90天喂养试验对大鼠中期血生化指标的影响 Table 23 Effect of rat tail type Ⅰ collagen 90-day feeding test on rat mid-term blood biochemical indicators

表24大鼠尾Ⅰ型胶原蛋白90天喂养试验对大鼠末期血生化指标的影响 Table 24 Effect of 90-day feeding test of rat tail type Ⅰ collagen on blood biochemical indicators in rats

2.3.3大体病理及组织学检查:由表25可见,以0.63、1.25、2.50g/kgBW剂量的大鼠尾Ⅰ型胶原蛋白灌胃给予大鼠90天,各受试物剂量组宰杀体重、肝脏、肾脏、脾脏和睾丸的重量及各脏器脏体比与对照组比较均无显著性差异(P>0.05)。2.3.3 Gross pathological and histological examination: It can be seen from Table 25 that the rat tail type Ⅰ collagen at doses of 0.63, 1.25, and 2.50 g/kg BW was given to rats by intragastric administration for 90 days, and the body weight, There was no significant difference in the weight of liver, kidney, spleen and testis and the viscera ratio of each organ compared with the control group (P>0.05).

表25大鼠尾Ⅰ型胶原蛋白90天喂养试验对大鼠脏器重量及脏体比的影响 Table 25 Effect of 90-day feeding test of rat tail type Ⅰ collagen on rat organ weight and viscera body ratio

由上述表25可知,大体解剖肉眼观察均未发现各脏器异常。大鼠肝、肾、胃及十二指肠、脾、睾丸(或卵巢)脏器的组织学检查结果为:肝脏:正常结构可清晰辩识,肝小叶排列整齐,肝细胞以中央静脉为轴心呈大致辐射状走向;大部分肝细胞形态正常,部分肝细胞可见轻度水样变性;对照组1例雌性性动物(1/20)和2.50g/kgBW剂量组1例雌性动物(1/20)可见肝细胞灶状坏死该病变在实验动物常有发生。肾脏:结构可清晰识别,肾单位呈均匀分布,肾小球和肾小管结构正常,未见间质细胞增生、炎性细胞渗出及肾小球萎缩等病变;部分肾曲管上皮细胞水样变性。心脏:组织结构能够识别,由心肌层及心内膜、心外膜组成。心肌纤维呈交错排列,为多核、分枝的横纹肌细胞,其间有少量结缔组织和血管。脾脏:脾组织结构易于辩认,由被膜向深层伸展形成结缔组织的小樑状间隔,血管穿行其中,白髓和红髓正常,偶见脾窦轻度扩张淤血。上述肝脏、肾脏、心脏和脾脏的改变为实验动物常见病变,对照组和高剂量组无组间差异,故认为与受试物无关。胃:胃壁结构易于识别,粘膜上皮形态正常,未见出血、坏死及炎性渗出,也无腺细胞组成的变化。十二指肠:粘膜、粘膜下层、肌层及浆膜各层均可清晰辩认,各层结构及其细胞正常,粘膜未见出血、坏死及炎性细胞浸润。睾丸:各组成部分易于识别,曲精小管界膜清晰,可见初级精母细胞、次级精母细胞、精子细胞和精子,未见出血、坏死及精细胞发育异常。卵巢:结构组成易于识别,皮质内可见不同发育阶段的卵泡(原始卵泡、初级卵泡、次级卵泡及成熟卵泡)和黄体,未见卵泡的发育异常及组织内出血、炎症等病理变化。胸腺:表面被以薄层结缔组织包膜,下方可见胸腺组织的正常结构,分皮质和髓质两部分。偶有少量脂肪细胞混杂胸腺组织间。未见明显病理变化。对照组和实验组无显著差异。肾上腺:表面被以薄层结缔组织包膜,下方可见肾上腺组织的正常结构,分表层的皮质和中央部髓质两部分。未见明显病理变化。肝、肾、脾、胃、十二指肠、睾丸或卵巢、心脏、胸腺及肾上腺组织均未见有意义的病理改变。It can be seen from the above Table 25 that no abnormalities were found in any organs by gross anatomy. The results of histological examination of rat liver, kidney, stomach, duodenum, spleen, testis (or ovary) viscera are as follows: liver: normal structure can be clearly identified, liver lobule is arranged neatly, and liver cells are centered on the central vein as the axis The heart was in a roughly radial direction; most of the liver cells were normal in shape, and some of the liver cells showed mild watery degeneration; 1 female animal in the control group (1/20) and 1 female animal in the 2.50g/kgBW dose group (1/20 20) Focal necrosis of liver cells can be seen. This lesion often occurs in experimental animals. Kidney: The structure can be clearly identified, the nephrons are evenly distributed, the structure of glomeruli and renal tubules is normal, no interstitial cell proliferation, inflammatory cell exudation, glomerular atrophy and other lesions are seen; some renal convoluted epithelial cells are watery transsexual. Heart: The tissue structure can be identified, consisting of the myocardium, endocardium, and epicardium. Myocardial fibers are staggered, multinucleated, branched striated muscle cells with a small amount of connective tissue and blood vessels in between. Spleen: The tissue structure of the spleen is easy to identify. The capsule stretches to the deep layer to form a trabecular septum of connective tissue. Blood vessels run through it. The white pulp and red pulp are normal. Splenic sinuses are occasionally slightly dilated and congested. The above-mentioned changes in liver, kidney, heart and spleen are common lesions in experimental animals, and there is no difference between the control group and the high-dose group, so it is considered to have nothing to do with the test substance. Stomach: The structure of the gastric wall is easy to identify, and the epithelium of the mucosa is normal. There is no hemorrhage, necrosis, inflammatory exudation, or changes in the composition of glandular cells. Duodenum: Each layer of mucosa, submucosa, muscular layer and serosa can be clearly identified, the structure and cells of each layer are normal, and there is no hemorrhage, necrosis and inflammatory cell infiltration in the mucosa. Testis: each component is easy to identify, the seminiferous tubule boundary membrane is clear, primary spermatocytes, secondary spermatocytes, spermatids and spermatozoa can be seen, no hemorrhage, necrosis and abnormal development of spermatocytes are seen. Ovary: The structural composition is easy to identify. Follicles of different development stages (primordial follicles, primary follicles, secondary follicles, and mature follicles) and corpus luteum can be seen in the cortex. Abnormal development of follicles and pathological changes such as hemorrhage and inflammation in the tissue are not seen. Thymus: The surface is covered with a thin layer of connective tissue, and the normal structure of thymus tissue can be seen below, which is divided into two parts: cortex and medulla. Occasionally, a small amount of adipocytes are mixed in the thymus tissue. No obvious pathological changes were seen. There was no significant difference between the control group and the experimental group. Adrenal gland: The surface is covered with a thin layer of connective tissue, and the normal structure of the adrenal gland tissue can be seen below, which is divided into two parts: the cortex on the surface and the medulla in the center. No obvious pathological changes were seen. There were no significant pathological changes in liver, kidney, spleen, stomach, duodenum, testis or ovary, heart, thymus and adrenal gland.

3小结:3 Summary:

3.1急性毒性试验:大鼠尾Ⅰ型胶原蛋白对雌、雄性大鼠经口急性毒性,MTD 均大于15.0g/kgBW。3.1 Acute toxicity test: rat tail type Ⅰ collagen has acute oral toxicity to female and male rats, and the MTD is greater than 15.0g/kgBW.

3.2遗传毒性试验:Ames试验、小鼠骨髓嗜多染红细胞微核试验均未见鼠尾Ⅰ型胶原蛋白有致突变作用。3.2 Genetic toxicity test: Ames test and mouse bone marrow polychromatic erythrocyte micronucleus test did not show mutagenic effect of rat tail type Ⅰ collagen.

3.3 90天喂养试验:以0.63、1.25、2.50g/kgBW剂量的鼠尾Ⅰ型胶原蛋白灌胃给予大鼠90天,结果显示:各受试物剂量组动物活动、生长正常,各受试物剂量组动物体重、增重和食物利用率与对照组比较均无显著性差异(P>0.05)。血液学检测指标各剂量组与对照组比较,雌雄各受试物剂量组的血常规指标与对照组比较均无显著性差异(P>0.05);血生化指标与对照组比较,雌雄各受试物剂量组的血生化指标均无显著性差异(P>0.05);各受试物剂量组心脏、胸腺、肝脏、肾脏、脾脏和睾丸的重量及各脏器脏体比与对照组比较无显著性差异(P>0.05);病理指标也未见由受试物引起的异常改变。故未见受试物对动物体重、食物利用率、血液学、血生化、脏体比和病理组织学检查有不良影响。3.3 90-day feeding test: 0.63, 1.25, 2.50 g/kg BW doses of rat tail type Ⅰ collagen were given to rats by gavage for 90 days. Compared with the control group, the body weight, weight gain and food utilization rate of the animals in the dosage group had no significant difference (P>0.05). Compared with the control group in each dose group of hematological detection index, there was no significant difference in the blood routine index of the male and female test substance dosage groups compared with the control group (P>0.05); There was no significant difference in the blood biochemical indexes of the drug dosage groups (P>0.05); the weights of heart, thymus, liver, kidney, spleen and testis and the viscera ratio of each organ in each drug dosage group were not significantly different from those of the control group. Sexual differences (P>0.05); pathological indicators also did not see abnormal changes caused by the test substance. Therefore, no adverse effects of the test substance on animal body weight, food utilization rate, hematology, blood biochemistry, visceral body ratio and histopathological examination were found.

Claims (5)

1.大鼠尾Ⅰ型胶原蛋白在制备防皱保湿和/或美白的产品中的应用。1. The application of rat tail type Ⅰ collagen in the preparation of anti-wrinkle moisturizing and/or whitening products. 2.根据权利要求1所述的应用,其特征在于:所述产品包括食品、化妆品和保健品中的至少一种。2. The application according to claim 1, wherein the product includes at least one of food, cosmetics and health products. 3.一种化妆品,其特征在于:该化妆品包括如下质量份的组分制成:大鼠尾Ⅰ型胶原蛋白2~3份;牡丹花提取物0.5~1份;蜂胶提取物0.6~1.2份;氢化聚癸烯3份;辛酸癸酸三甘油酯4份;二甲基硅油3份;鲸蜡醇1.2份;山嵛醇0.5份;异十三醇异壬酸酯4份;水100份;甘油3份;丁二醇3份;甘油硬脂酸(SE)1份;山嵛醇聚醚-20 1.5份;乙二胺四乙酸二钠0.03份;丙烯酸钠酰二甲基牛磺酸钠共聚物0.5份;防腐剂0.2份;香精0.1~0.3份。3. A cosmetic, characterized in that: the cosmetic comprises the following components by mass: 2 to 3 parts of rat tail type I collagen; 0.5 to 1 part of peony flower extract; 0.6 to 1.2 parts of propolis extract ; 3 parts hydrogenated polydecene; 4 parts caprylic capric triglyceride; 3 parts simethicone; 1.2 parts cetyl alcohol; 0.5 parts behenyl alcohol; 4 parts isotridecanyl isononanoate; 100 parts water ; 3 parts of glycerin; 3 parts of butanediol; 1 part of glyceryl stearic acid (SE); 1.5 parts of beheneth-20; 0.03 parts of disodium edetate; 0.5 parts of sodium copolymer; 0.2 parts of preservatives; 0.1 to 0.3 parts of essence. 4.权利要求3中化妆品的制备方法,包括如下步骤:1)将氢化聚癸烯、辛酸癸酸三甘油酯、二甲基硅油、鲸蜡醇、山嵛醇和异十三醇异壬酸酯混合,加热得到A相;4. the preparation method of cosmetics in claim 3, comprises the steps: 1) hydrogenated polydecene, caprylic triglyceride, simethicone, cetyl alcohol, behenyl alcohol and isotridecyl isononanoate Mix and heat to obtain phase A; 2)将大鼠尾Ⅰ型胶原蛋白、牡丹花提取物水、甘油、丁二醇、甘油硬脂酸、山嵛醇聚醚-20和乙二胺四乙酸二钠混合得到B相,然后将步骤1)中得到的所述A相加入所述B相中,预乳化、均质;2) Mix rat tail type Ⅰ collagen, peony flower extract water, glycerin, butylene glycol, glyceryl stearic acid, beheneth-20 and disodium edetate to obtain phase B, and then The phase A obtained in step 1) is added to the phase B, pre-emulsified and homogenized; 3)经步骤2)中所述A相与所述B相经处理后,加入丙烯酸钠酰二甲基牛磺酸钠共聚物混合;3) After the A phase and the B phase described in step 2) are treated, add sodium acrylate sodium acyl dimethyl taurate copolymer and mix; 4)将步骤3)处理后的体系冷却,然后加入防腐剂、香精均质,即得到所述化妆品。4) Cool the system after the treatment in step 3), and then add preservatives and essence to homogenize to obtain the cosmetic. 5.根据权利要求4中的制备方法,其特征在于:步骤1)中,所述加热至80℃;5. The preparation method according to claim 4, characterized in that: in step 1), the heating is to 80°C; 步骤2)中,所述预乳化的时间为5min,所述均质的时间为3min;In step 2), the time of the pre-emulsification is 5min, and the time of the homogenization is 3min; 步骤3)中,所述体系冷却至45℃;In step 3), the system is cooled to 45°C; 步骤4)中,所述均质的时间为2min。In step 4), the homogenization time is 2 minutes.
CN201910520678.5A 2019-06-17 2019-06-17 The application of big rat-tail Type I collagen albumen Pending CN110200839A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910520678.5A CN110200839A (en) 2019-06-17 2019-06-17 The application of big rat-tail Type I collagen albumen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910520678.5A CN110200839A (en) 2019-06-17 2019-06-17 The application of big rat-tail Type I collagen albumen

Publications (1)

Publication Number Publication Date
CN110200839A true CN110200839A (en) 2019-09-06

Family

ID=67792940

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910520678.5A Pending CN110200839A (en) 2019-06-17 2019-06-17 The application of big rat-tail Type I collagen albumen

Country Status (1)

Country Link
CN (1) CN110200839A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008032054A2 (en) * 2006-09-15 2008-03-20 Novathera Limited Composite material comprising a tissue matrix compound and a bioactive glass
CN109431850A (en) * 2018-03-16 2019-03-08 广东众尔健生物科技有限公司 A kind of application of Collagen type-I in cosmetic field

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008032054A2 (en) * 2006-09-15 2008-03-20 Novathera Limited Composite material comprising a tissue matrix compound and a bioactive glass
CN109431850A (en) * 2018-03-16 2019-03-08 广东众尔健生物科技有限公司 A kind of application of Collagen type-I in cosmetic field

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
冯年平等: "《中药经皮给药与功效性化妆品》", 31 May 2019, 中国医药科技出版社 *
宝拉•培冈等: "《美丽圣经:升级版》", 30 April 2017, 广西师范大学出版社 *
李虹: "《广东省医疗美容医师培训教材系列丛书 美容技术分册》", 30 November 2015, 人民军医出版社 *
陈国珍: "《女性美容宜与忌》", 31 July 2004, 人民军医出版社 *
马清温等: "《中国60种珍稀濒危药用植物资源与利用》", 31 December 2017, 中国铁道出版社 *

Similar Documents

Publication Publication Date Title
Li et al. Mitochondrial transfer from bone marrow mesenchymal stem cells to motor neurons in spinal cord injury rats via gap junction
WO2022051883A1 (en) Preparation method for and application of exosome derived from human umbilical cord mesenchymal stem cells
CN115074393B (en) Pichia pastoris fermentation lysate filtrate, preparation method and application
CN108354947A (en) Load purposes of the human pluripotent stem cells excretion body of resveratrol on preparing treatment refractory skin wound relevant disease drug
CN115414397B (en) Application of teasel root-derived extracellular vesicle-like nano-particles in preparation of medicines for preventing or treating orthopedic diseases
CN102697812B (en) Method for extracting exosome from chicken bile and application of exosome in immunology
CN110123838A (en) Load human pluripotent stem cells excretion body of resveratrol and preparation method thereof and purposes
CN116173112B (en) Traditional Chinese medicine formula probiotic composition, preparation method and application thereof in improving male sexual function
CN110123839B (en) Human pluripotent stem cell exosome loaded with photosensitive drug, preparation and application thereof
Liu et al. A tannic acid doped hydrogel with small extracellular vesicles derived from mesenchymal stem cells promotes spinal cord repair by regulating reactive oxygen species microenvironment
CN116904394A (en) Preparation method and application of anti-inflammatory mesenchymal stem cell-derived exosomes
JP2021533820A (en) Methods and compositions for promoting cell proliferation and tissue remodeling
De La Haba et al. Myogenesis of avian striated muscle in vitro: role of collagen in myofiber formation.
CN110241071A (en) A kind of normal renal tubule primary cell of people and its Isolation and culture and application
CN112708652A (en) Avocado oil-in-water liquid state fermentation product and preparation method and application thereof
Lazzarini-Robertson JR Effects of heparin on the uptake of lipids by isolated human and animal arterial endothelial type cells
CN111407879A (en) Application of Chinese yam protein extract in preparation of medicine for treating erectile dysfunction
RU2485133C2 (en) Protein-polypeptide complex possessing tissue-specific regenerative-reparative and rejuvenating action on skin tissue, method for preparing it, and pharmaceutical composition thereof
KR102724512B1 (en) Skin whitening composition containing skeletal muscle stem cell-derived exosomes as an effective ingredient
RU2460736C1 (en) Protein-polypeptide complex (ppc) possessing tissue specific repair and rejuvenating action on skin tissue, method for preparing protein-polypeptide complex possessing tissue specific repair and rejuvenating action on skin tissue, and pharmaceutical composition of ppc possessing antihypoxic, immunomodulatory, tissue specific repair and rejuvenating action on skin tissue and mucous membranes, with rejuvenating effect
CN110200839A (en) The application of big rat-tail Type I collagen albumen
Creasy et al. Effects of mono-(2-ethylhexyl) phthalate and mono-n-pentyl phthalate on the ultrastructural morphology of rat Sertoli cells in Sertoli/germ cell co-cultures: Correlation with the in vivo effects of di-n-pentyl phthalate
CN115317519B (en) Application of adipose-derived mesenchymal stem cells in preparation of medicine for treating cat fatty liver
DE69929189T2 (en) A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiency
CN109498644A (en) Application of the Chinese medicine sulphation Codonopsis pilosula polysaccharide as antioxidant

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190906